| Literature DB >> 30191275 |
Irene Katharina Sigmund1, Reinhard Windhager2, Florian Sevelda2, Kevin Staats2, Stephan Engelbert Puchner2, Sandra Stenicka2, Florian Thalhammer3, Johannes Holinka2.
Abstract
PURPOSE: The aim of this study was to evaluate the pre-operative performance of an automated multiplex PCR (mPCR) system in patients with suspected periprosthetic joint infection (PJI).Entities:
Keywords: Diagnosis; Low-grade infections; Low-virulent microorganisms; Multiplex PCR system; Periprosthetic joint infection
Year: 2018 PMID: 30191275 PMCID: PMC6647720 DOI: 10.1007/s00264-018-4136-z
Source DB: PubMed Journal: Int Orthop ISSN: 0341-2695 Impact factor: 3.075
Positive, negative, and overall percent (%) agreement and Cohen’s kappa coefficient between the mPCR system and the conventional culture of synovial fluid samples in the total study cohort, after total knee arthroplasty (TKA) and total hip arthroplasty (THA) with their 95% confidence interval
| Positive % agreement | Negative % agreement | Overall % agreement | Kappa | |
|---|---|---|---|---|
| Total | 75.0 (57.6–86.9) | 91.4 (80.8–96.6) | 85.6 (78.3–92.8) | 0.68 (0.52–0.84) |
| TKA | 73.7 (50.8–99.4) | 93.8 (78.6–99.2) | 86.3 (76.8–95.7) | 0.70 (0.49–0.91) |
| THA | 72.7 (42.8–90.5) | 86.4 (65.6–95.9) | 81.8 (68.7–95.0) | 0.59 (0.29–0.89) |
Distribution of microorganisms detected in the synovial fluid (SF) by multiplex PCR (mPC) and conventional culture in the study cohort
| Isolated microorganism | mPCR ( | SF culture ( |
|---|---|---|
|
| 13 | 18 |
| Coagulase-negative Staphylococci | 7 | 5 |
| 2 | 1 | |
|
| 3 | 0 |
|
| 2 | 2 |
| 2 | 2 | |
|
| 1 | 1 |
|
| 1 | 1 |
|
| 1 | 0 |
| 1 | 1 | |
|
| 1 | 1 |
| 0 | 1 | |
|
| 0 | 1 |
| Total | 34 | 34 |
Sensitivity, specificity, positive and negative likelihood ratio (LR+, LR−), area under the curve (AUC), and positive (PPV) and negative predictive value (NPV) with their 95% confidence interval of the multiplex PCR system, conventional culture of the synovial fluid (SF) samples, and the combination of both test methods according to the MSIS criteria
| mPCR | Conventional culture SF | Combination | |
|---|---|---|---|
| Sensitivity | 71.1% (55.1–83.0) | 84.2% (69.1–92.8) | 92.1% (78.3–97.9) |
| Specificity | 96.2% (86.1–99.6) | 100.0% (91.6–100) | 96.2% (86.1–99.6) |
| LR+ | 18.47 (4.68–72.99) | – | 23.95 (6.13–93.51) |
| LR− | 0.30 (0.18–0.50) | 0.16 (0.08–0.33) | 0.08 (0.03–0.24) |
| AUC | 0.84 (0.76–0.91) | 0.92 (0.86–0.98) | 0.94 (0.89–0.99) |
| PPV | 93.1% (83.9–100) | 100% (100) | 94.6% (87.3–100) |
| NPV | 82.0% (72.3–91.6) | 89.7% (81.8–97.5) | 94.3% (88.1–100) |
Fig. 1Receiver operating characteristic curves for diagnostic accuracy of periprosthetic joint infection based on multiplex PCR (mPCR), synovial fluid culture (SF culture), and the combination of both test methods (combined)
Detected gene resistance marker in the multiplex PCR Unyvero i60 ITI application compared to the antibiogram of the conventional culture in synovial fluid samples with concordant microorganisms
| Concordant microorganisms | mPCR gene resistance marker | Culture-resistance |
|---|---|---|
|
| Macrolides/lincosamides [ | No resistance |
| Coagulase-negative Staphylococci | Aminoglycosides | Gentamicin |
| Macrolides/lincosamides [ | Oxacillin | |
| Ciprofloxacin | ||
|
| No resistance | No resistance |
| Coagulase-negative Staphylococci | No resistance | No resistance |
| No resistance | Clindamycin | |
|
| Fluoroquinolones [ | No resistance |
|
| No resistance | No resistance |
|
| No resistance | No resistance |
|
| Macrolides/lincosamides [ | Erythromycin, clindamycin |
| Glycopeptide [ | ||
|
| No resistance | No resistance |
|
| Macrolides/lincosamides [ | Erythromycin, clindamycin |
|
| Rifampicin [ | Fosfomycin |
|
| Macrolides/lincosamides [ | Erythromycin, clindamycin |
|
| No resistance | Ciprofloxacin |
|
| No resistance | Erythromycin, clindamycin |
|
| No resistance | Erythromycin, clindamycin |
| No resistance | No resistance | |
|
| No resistance | No resistance |
|
| No resistance | No resistance |
|
| Macrolides/lincosamides [ | Erythromycin, clindamycin |
| Aminoglycosides | ||
|
| No resistance | Erythromycin, clindamycin |
| No resistance | No resistance | |
| No resistance | Erythromycin, clindamycin | |
| Doxycyclin |
Results of the literature with listed test material of each study, overall percent (%) agreement between mPCR and culture, sensitivity and specificity of the mPCR, synovial fluid, sonication, and tissue culture
| Present study | Morgenstern et al. [ | Renz et al. [ | Achermann et al. [ | Portillo et al. [ | Hischebeth et al. [ | Borde et al. [ | Suda et al. [ | |
|---|---|---|---|---|---|---|---|---|
| Test material | ||||||||
| mPCR | Synovial fluid | Synovial fluid | Sonication fluid | Sonication fluid | Sonication fluid | “Pooled PCR” | Tissue samples | Tissue samples |
| Culture | Synovial fluid | Synovial fluid | Sonication fluid | Sonication fluid | sonication + tissue | Sonication fluid | Tissue samples | Tissue samples |
| Used criteria | MSIS/EBJIS | EBJIS | EBJIS | Modified EBJIS | Modified EBJIS | MSIS | nm | MSIS |
| Overall % agreement | 86% | 82% | 64% | 57% | nm | nm | 82% | nm |
| Sensitivity mPCR | 71%/52% | 60% | 51% | 78% | 96% | 67% | nm | 31% |
| Sensitivity culture | ||||||||
| Synovial | 84%/57% | 52% | nm | nm | nm | nm | nm | nm |
| Sonication | 86%/66% | 61% | 58% | 62% | 71% | 89% | nm | nm |
| Tissue | 74%/60% | 45% | 51% | nm | 67% | 67% | nm | 85% |
| Specificity mPCR | 90%/100% | 89% | 94% | nm | 100% | 100% | nm | 100% |
| Specificity culture | ||||||||
| Synovial | 100%/100% | 98% | nm | nm | nm | nm | nm | nm |
| Sonication | 100%/100% | 91% | 100% | nm | 100% | 62% | nm | nm |
| Tissue | 95%/100% | 96% | 100% | nm | 98% | 82% | nm | 100% |
nm, not mentioned in the published paper; “Pooled PCR”, aspirate and sonication fluid